证券代码：603270 证券简称：金帝股份 公告编号：2025-111 2、协议有效期 2025 年 11 月 25 日至 2026 年 11 月 25 日 山东金帝精密机械科技股份有限公司 关于开展票据池业务的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、本次票据池业务基本情况 近日，山东金帝精密机械科技股份有限公司（以下简称"公司"）与兴业银 行股份有限公司聊城分行（以下简称"兴业银行"）签署了《票据池业务合作协 议》和《最高额质押合同》，根据兴业银行服务能力及公司业务需求，确定兴业 银行票据池额度为 3.4 亿元，未超过董事会及股东会审议额度，在上述额度及有 效期内，可循环使用。 二、内部决策程序 公司于 2025 年 10 月 29 日召开了第三届董事会第二十次会议，2025 年 11 月 17 日召开 2025 年第三次临时股东会，均审议通过了《关于公司开展票据池业 务的议案》。根据公司业务发展需要，提高公司流动资产的使用效率，公司及控 股子公司（含实施期限内新设立、收购的控股子公司）拟与合作银行开展 ...

关于对外担保进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象 被担保人名称 金源（山东）新能源科技发展有限 公司 本次担保金额 1,000.00 万元 实际为其提供的担保余额 8,000.00 万元 是否在前期预计额度内 是 □否 □不适用：_________ 本次担保是否有反担保 是 ☑否 □不适用：_________ 证券代码：603270 证券简称：金帝股份 公告编号：2025-110 山东金帝精密机械科技股份有限公司 担保对象及基本情况 累计担保情况 | 对外担保逾期的累计金额（万元） | 0.00 | | --- | --- | | 截至本公告日上市公司及其控股 | 175,500.00 | | 子公司对外担保总额（万元） | | | 对外担保总额占上市公司最近一 期经审计净资产的比例（%） | 81.52 | | | □对外担保总额（含本次）超过上市公司最 | | | 近一期经审计净资产 50% | | | □对外担保总额（含本次）超过上市公司最 | | 特别风险提示（如有请勾选 ...

Core Viewpoint - The strategic cooperation agreement between Jindi Co., Ltd. and Dongpei Industrial Co., Ltd. aims to enhance collaboration in the field of humanoid robot harmonic reducer assemblies and key components, leveraging both companies' strengths in manufacturing, research, and technology [1][2]. Group 1: Strategic Cooperation - Jindi Co., Ltd. and Dongpei Industrial Co., Ltd. signed a strategic cooperation letter of intent to explore the feasibility of establishing a joint venture or other collaborative structures [1]. - The cooperation will focus on integrating technology, manufacturing, and market resources to improve product competitiveness and market penetration [1][2]. - Both companies will share market information and potential customer lists voluntarily, and explore future collaboration in market promotion, brand cooperation, and supply chain synergy [1]. Group 2: Product Development and Market Position - Jindi Co., Ltd. aims to combine its manufacturing and research advantages with Dongpei's technical and product application experience to transform R&D strengths into competitive end products [2]. - The company’s main products include bearing retainers and precision components, with applications in automotive power systems and emerging industries such as electric vertical take-off and landing aircraft [2]. - The company has innovatively adopted precision stamping to replace forging in the development of harmonic reducer flexible wheel initial blanks, achieving import substitution and meeting high fatigue strength requirements [3]. Group 3: Future Prospects - Jindi Co., Ltd. is committed to continuous product model development and testing, while actively expanding its customer base along the industrial chain to lay the foundation for future mass production and market expansion [3]. - Currently, the flexible wheel initial blank products have not generated significant revenue, thus not impacting the company's overall performance [3].

Group 1: Shareholding Changes - Company Zhaoyi Innovation announced that several directors and senior management personnel plan to reduce their holdings by a total of 249,000 shares, with specific reductions from the vice chairman and general manager, as well as other vice presidents [1] - Company Super Aerospace announced a stock suspension due to its controlling shareholders planning a significant matter that may lead to a change in control [2] - Company Haosai is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [5] Group 2: Major Contracts and Projects - Company Dajin Heavy Industry's wholly-owned subsidiary signed a contract worth approximately 1.339 billion yuan for a European offshore wind farm project, which represents 35.41% of the company's audited revenue for 2024 [3] - Company Ruifeng New Materials plans to increase capital by 200 million yuan in a related party to advance a lithium hexafluorophosphate project [6] Group 3: Regulatory Actions - Company Jushi Chemical received a notice from the CSRC regarding an investigation for suspected violations of information disclosure laws [4] - Company Huosai is also under investigation by the CSRC for similar reasons [5] Group 4: Investment and Acquisitions - Company Gao Neng Environment plans to acquire 45.2% equity in three mining companies [7] - Company Aerospace Electric intends to purchase 32% equity in Shenzhen Aerospace Electric Motor System Co., Ltd. through public bidding [8]

Group 1 - Central Plaza received a warning letter from Jiangsu Securities Regulatory Commission due to failure to timely disclose significant litigation progress and accounting treatment, affecting the accuracy of the 2025 semi-annual report [4] - Jiaron Technology announced a stock suspension as it plans a major asset restructuring through share issuance and fundraising, with the suspension expected to last no more than 10 trading days [5] - Maiwei Co. is undergoing a debt restructuring involving accounts receivable totaling 371 million yuan, with an estimated loss of 85.465 million yuan, aimed at accelerating cash flow recovery and reducing receivables risk [6] Group 2 - New World plans to use up to 850 million yuan of idle fundraising to purchase financial products or deposits, having previously used 575 million yuan for similar purposes [7] - Huyou Pharmaceutical's HYP-6589 tablet clinical trial application for treating advanced non-small cell lung cancer has been accepted by the National Medical Products Administration [8] - Sunshine Nuohuo's lawsuit against Hengsheng Pharmaceutical has entered the second instance, with the original claim amounting to 20 million yuan and a counterclaim of 740.73 thousand yuan [9] Group 3 - Guolian Aquatic received a warning letter from Guangdong Securities Regulatory Commission for non-operating fund occupation by its controlling shareholder, with a total borrowing of 7.8 million yuan [10] - Renfu Pharmaceutical's application for the marketing authorization of Dexmethylphenidate capsules has been accepted, targeting ADHD treatment [11] - Jindi Co. signed a strategic cooperation letter with Dongpei Co. to explore collaboration on humanoid robot harmonic reducer assemblies [12] Group 4 - Yuyuan Co. repurchased 1 million A-shares for a total payment of approximately 5.386 million yuan, as part of a broader repurchase plan of 200-300 million yuan [13] - Yuheng Pharmaceutical's executives increased their holdings by 1.12% through a judicial auction, acquiring 25 million shares [14] - Zhonghuan Co. shareholders plan to reduce their holdings by 1.02% and 0.24% respectively, citing personal funding needs [15] Group 5 - Huibo Co. won a contract for the Iraq NaftKhana oilfield restoration project worth approximately 1.596 billion yuan, expected to significantly impact 2026-2027 performance [17] - Dajin Heavy Industry's subsidiary signed a contract for a European offshore wind farm project valued at approximately 1.339 billion yuan, representing 35.41% of the company's 2024 audited revenue [18]

Core Viewpoint - The strategic cooperation agreement between Jindi Co., Ltd. and Dongpei Industrial Co., Ltd. aims to enhance collaboration in the field of humanoid robot harmonic reducer assemblies and key components, leveraging both companies' strengths in manufacturing, research, and technology [1][2]. Group 1: Strategic Cooperation - Jindi Co., Ltd. and Dongpei Industrial Co., Ltd. signed a strategic cooperation letter of intent to explore the feasibility of establishing a joint venture or other collaborative structures [1]. - The cooperation will focus on integrating technology, manufacturing, and market resources to improve product competitiveness and market penetration [1][2]. - Both companies will share market information and potential customer lists voluntarily, and explore future collaboration in market promotion, brand cooperation, and supply chain synergy [1]. Group 2: Product Development and Market Position - Jindi Co., Ltd. aims to combine its manufacturing and research advantages with Dongpei's technical and product application experience to transform R&D strengths into competitive end products [2]. - The company's main products include bearing retainers and precision components, with applications in automotive power systems and emerging industries such as electric vertical takeoff and landing aircraft motors and humanoid robot motors [2]. - The company has innovatively adopted precision stamping to replace forging in the development of harmonic reducer flexible wheel preforms, achieving import substitution and meeting high fatigue strength requirements [3]. Group 3: Production and Cost Efficiency - Jindi Co., Ltd. is working on seamless integration of pre-forming and precision processing stages to reduce costs and improve efficiency in the supply chain [3]. - The company is actively expanding its product model development and testing while seeking to broaden its customer base in the industry chain [3]. - Currently, the flexible wheel preform products have not generated significant revenue, thus not impacting the company's overall performance [3].

Group 1 - Daikin Heavy Industries' subsidiary signed a contract worth approximately 1.339 billion yuan for an offshore wind farm project in Europe, accounting for 35.41% of the company's audited revenue for 2024 [1] Group 2 - Zhaoyi Innovation announced that several board members and senior management plan to reduce their holdings by a total of 249,000 shares, due to personal financial needs, with the reduction period set from December 15, 2025, to March 14, 2026 [2] Group 3 - Jushi Chemical received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure laws, while the company's operations continue normally [3][6] Group 4 - Chaozhuo Aerospace announced a stock suspension due to major matters being planned by its controlling shareholders, which may lead to a change in control [4] Group 5 - Heng Rui Medicine received approval for clinical trials of SHR-1139 injection, a biopharmaceutical with no similar products approved for sale domestically or internationally, with a cumulative R&D investment of approximately 100.13 million yuan [5] Group 6 - Huayou Pharmaceutical's HYP-6589 tablet for treating advanced non-small cell lung cancer received a clinical trial application acceptance notice, with no similar products approved for sale [8] Group 7 - Renfu Pharmaceutical's application for the marketing license of Dexamethasone L-amphetamine capsules was accepted, aimed at treating ADHD, with a cumulative R&D investment of approximately 90 million yuan [10] Group 8 - Huibo Group won a bid for a 1.596 billion yuan project for the restoration of an oil field in Iraq [10]

Core Viewpoint - The company JinDi Co., Ltd. (603270.SH) has signed a strategic cooperation letter of intent with Dongpei Industrial Co., Ltd. to explore collaboration in humanoid robot harmonic reducer assemblies and key components [1] Group 1: Strategic Cooperation - The cooperation is based on principles of equality, mutual benefit, complementary advantages, integrity, and joint development [1] - Both companies aim to leverage JinDi's manufacturing and R&D capabilities alongside Dongpei's technical and product application experience [1] - The parties will discuss the feasibility of establishing a joint venture or other cooperative structures [1] Group 2: Areas of Focus - The collaboration will involve communication and evaluation regarding market, technology, and investment matters [1] - The goal is to promote long-term and stable cooperative development between the two companies [1]

Regulatory Actions - Haosai is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure, but the company states that its operations remain normal and the investigation will not significantly impact management [2] - Central Plaza and its executives received a warning letter from the Jiangsu Securities Regulatory Bureau for failing to timely disclose significant litigation progress, which led to inaccurate financial reporting [3] - Guolian Aquatic received a warning letter from the Guangdong Securities Regulatory Bureau for non-operating fund occupation by its controlling shareholder, which was not disclosed in a timely manner [9] Corporate Actions - Jiarong Technology is planning a major asset restructuring and has suspended trading of its shares, expected to last no more than 10 trading days [4] - Maiwei Co. announced a debt restructuring totaling 371 million yuan, with an expected loss of 85.465 million yuan, aimed at improving cash flow and reducing receivables risk [5] - New World plans to use up to 850 million yuan of idle fundraising to purchase financial products or deposits, with a total of 575 million yuan already invested in such products [6] Legal Matters - Sunshine Nuohuo's lawsuit against Hengsheng Pharmaceutical has entered the second instance, with the original claim amounting to 20 million yuan and a counterclaim of 7.4073 million yuan [8] Product Development - Huyou Pharmaceutical's HYP-6589 tablet has received acceptance for clinical trial applications for treating advanced non-small cell lung cancer [7] - Renfu Pharmaceutical's application for the marketing license of a new ADHD treatment has been accepted, with no similar products currently available in the domestic market [10] Strategic Partnerships - Jindi Co. signed a strategic cooperation letter of intent with Dongpei Co. to explore collaboration on humanoid robot harmonic reducer assemblies and key components [11] Share Buybacks and Holdings - Yuyuan Co. has repurchased 1 million A-shares for a total of approximately 5.3864 million yuan as part of a buyback plan [12] - Yuheng Pharmaceutical's executives increased their holdings by 1.12%, acquiring a total of 25 million shares [13] Major Contracts - Huayou Huibo has been awarded a contract worth 225 million USD for the Iraq NaftKhana oilfield project, which is expected to significantly impact future earnings [16] - Dajin Heavy Industry's subsidiary signed a contract worth approximately 1.339 billion yuan for a European offshore wind farm project, representing 35.41% of the company's expected annual revenue [17]

证券代码：603270 证券简称：金帝股份 公告编号：2025-109 山东金帝精密机械科技股份有限公司 关于签订战略合作意向书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 履约的重大风险及不确定性：本次签订的《战略合作意向书》系双方为 加强战略合作而订立的框架性协议，仅作为双方合作意愿和基本原则的框架性、 意向性的初步约定，不涉及具体金额，相关具体合作项目由双方根据业务发展需 求另行签订相关合作协议进行约定，敬请广大投资者注意投资风险。 对上市公司当年业绩的影响：本次相关协议的签署对公司业务和经营的 独立性不产生影响，不会对公司当年经营业绩产生重大影响。 特别风险提示：公司将根据合作事项进展情况，严格按照相关法律法规 和规范性文件的要求，及时履行信息披露义务，敬请投资者注意投资风险。 一、合作意向书签订的基本情况 近日，山东金帝精密机械科技股份有限公司（以下简称"公司"）与东培工 业股份有限公司（以下简称"东培股份"）签署了《战略合作意向书》，本着平等 互利、优势互补、诚信合作、共同发展的原则，确认 ...